• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Oruka Therapeutics, Inc. - Common Stock (NQ:ORKA)

    63.99 +0.81 (+1.29%)
    Streaming Delayed Price Updated: 3:43 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 905,623
    Open 63.36
    Bid (Size) 63.89 (100)
    Ask (Size) 64.10 (400)
    Prev. Close 63.18
    Today's Range 61.63 - 65.50
    52wk Range 8.910 - 91.00
    Shares Outstanding 14,410,143
    Dividend Yield 30.25%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120% ↗
    This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical trials. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company ↗
    This clinical-stage biotech develops targeted radiopharmaceutical therapies for cancer using a proprietary miniprotein platform. 
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance

    Performance

    YTD
    +126.4%
    +126.4%
    1 Month
    +4.3%
    +4.3%
    3 Month
    +98.7%
    +98.7%
    6 Month
    +126.1%
    +126.1%
    1 Year
    +565.2%
    +565.2%

    More News

    Read More
    News headline image
    Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried? ↗
    Via The Motley Fool
    News headline image
    Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    These stocks are gapping in today's session ↗
    Via Chartmill
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools ↗
    Via The Motley Fool
    News headline image
    What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    VR Adviser Adds Over 1 Million Savara Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics to Participate in Multiple Upcoming Conferences
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces New Board Member and Board Transition
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga
    News headline image
    AutoZone To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Via Benzinga
    News headline image
    Oruka Therapeutics Inc (NASDAQ:ORKA) Reports Q3 2025 Results, Beats EPS Estimates and Provides Clinical Pipeline Updates ↗
    Via Chartmill
    News headline image
    Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Oruka Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Oruka Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Oruka Therapeutics, Inc. - Common Stock trade on?
    Oruka Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Oruka Therapeutics, Inc. - Common Stock?
    The ticker symbol for Oruka Therapeutics, Inc. - Common Stock is ORKA on the Nasdaq Stock Market
    What is the current price of Oruka Therapeutics, Inc. - Common Stock?
    The current price of Oruka Therapeutics, Inc. - Common Stock is 63.99
    When was Oruka Therapeutics, Inc. - Common Stock last traded?
    The last trade of Oruka Therapeutics, Inc. - Common Stock was at 05/14/26 03:43 PM ET
    What is the market capitalization of Oruka Therapeutics, Inc. - Common Stock?
    The market capitalization of Oruka Therapeutics, Inc. - Common Stock is 922.18M
    How many shares of Oruka Therapeutics, Inc. - Common Stock are outstanding?
    Oruka Therapeutics, Inc. - Common Stock has 922M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.